Document is current
Any future updates will be listed below
-
Authors
Rust, Ruslan https://orcid.org/0000-0003-3376-3453
Weber, Rebecca Z. https://orcid.org/0000-0002-6912-3573
Generali, Melanie https://orcid.org/0000-0001-8396-3256
Kehl, Debora
Bodenmann, Chantal
Uhr, Daniela
Wanner, Debora
Zürcher, Kathrin J.
Saito, Hirohide https://orcid.org/0000-0002-8570-5784
Hoerstrup, Simon P.
Nitsch, Roger M.
Tackenberg, Christian https://orcid.org/0000-0002-0019-3055
-
Funding
Funding for this research was provided by:
Stiftung Forschung 3R (OC-2020-002)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_195902)
Mäxi Foundation
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 24 August 2022
First Online: 16 September 2022
Declarations
:
: The use of human iPSC lines was approved by the Zurich Cantonal Ethics Committee (Approval Nr.: 2014–0430). Animal experiments were performed in accordance with governmental and institutional (University of Zurich) guidelines and have been approved by the Cantonal Veterinary Office of Zurich (License number: 31687).
: Not applicable.
: Hirohide Saito owns shares and is outside director of aceRNA Technologies, Ltd.
